Form 4: Ategrity Specialty Executive Option Vesting Disclosure
Statement of Changes in Beneficial Ownership
President and Chief Underwriting Officer Chris Schenk vested 21,981 stock options following the achievement of performance criteria.
Summary
- Chris Schenk, President and Chief Underwriting Officer of Ategrity Specialty Insurance Co Holdings, reported the vesting of 21,981 stock options.
- The options were part of a 43,963-share grant originally issued on January 1, 2022.
- Vesting was contingent upon the company meeting specific performance criteria for the 2024 and 2025 fiscal years.
- The transaction date for the vesting event is recorded as March 5, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative disclosure regarding executive compensation and does not signal a change in company strategy or financial health.
Positives
- Successful achievement of performance-based vesting criteria for the 2024 and 2025 fiscal years.
- Alignment of executive compensation with company performance metrics.
Future Outlook
The remaining 50% of the original 2022 option grant remains subject to future performance or time-based vesting conditions as per the original agreement.
Industry Context
StockSavvy.ai notes that performance-based equity vesting is a standard governance practice in the specialty insurance sector to ensure executive incentives are tied to underwriting profitability and growth targets.
Comparison to Industry Standards
- The use of multi-year performance criteria for executive stock options is consistent with best practices among publicly traded specialty insurers.
- The exercise price and vesting structure align with typical long-term incentive plans (LTIP) seen in mid-cap financial services firms.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity compensation event.
Next Steps
- Reporting person may choose to exercise the vested options at the $10.66 strike price.
Key Dates
| Date | Description |
|---|---|
| 01/01/2022 | Original grant date of the stock options. |
| 03/05/2026 | Date of the vesting transaction. |
| 05/07/2026 | Date of the filing signature. |
Keywords
Ategrity Specialty, ASIC, Form 4, Executive Compensation, Stock Options, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.